Tag: T cell engagers

Ardigen and VERAXA Biotech are collaborating to enhance precision oncology through AI-driven drug discovery, optimizing cancer target selection for T cell engagers and antibody-drug conjugates. This partnership aims to minimize toxicities and improve success rates in cancer therapies. Read more